Glaxo Wellcome's MMP inhibitor shows potential in treating sepsis in early clinical study Oct. 2, 1998
Review of the preclinical activity of GAR-936, a glycylcycline antibiotic with clinical potential Oct. 2, 1998
ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action Oct. 1, 1998
RSS